About Takeda Pharmaceuticals
Takeda Pharmaceuticals is a company based in Tokyo (Japan) founded in 1781. It operates as a Direct-to-Consumer (D2C), and Professional Services. The company has 47,450 employees as of March 31, 2024. Takeda Pharmaceuticals has completed 19 acquisitions, including Adaptate Biotherapeutics, Ariad Pharmaceuticals and IDM Pharma. Takeda Pharmaceuticals offers products and services including Oveporexton (TAK-861), Plasma-Derived Therapies, and Oncology Treatments.
- Headquarter Tokyo, Japan
- Employees 47450 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Takeda Pharmaceutical Co. Ltd.
-
Annual Revenue
$29.18 B (USD)7.45as on Mar 31, 2024
-
Net Profit
$687.67 M (USD)-25.08as on Mar 31, 2024
-
EBITDA
$8.86 B (USD)10.28as on Mar 31, 2024
-
Latest Funding Round
$30.9 B (USD), Debt – Conventional
Nov 05, 2018
- Investors
-
Employee Count
47450
as on Mar 31, 2024
-
Investments & Acquisitions
Adaptate Biotherapeutics
& 18 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Takeda Pharmaceuticals
Takeda Pharmaceuticals is a publicly listed company on the TSE with ticker symbol 4502 in Japan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Takeda Pharmaceuticals
Takeda Pharmaceuticals offers a comprehensive portfolio of products and services, including Oveporexton (TAK-861), Plasma-Derived Therapies, and Oncology Treatments. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Developed for treating narcolepsy type 1 in patients.
Innovated for chronic rare diseases using plasma technology.
Created to address cancer with innovative therapeutic solutions.
Unlock access to complete
Unlock access to complete
Software Development Team
330 people
Leadership Team
187 people
Data Analysis and Operations Team
65 people
Operations Team
60 people
Head Team
47 people
Legal and Compliance
43 people
Human Resources and Administration
42 people
Product Management Team
40 people
Unlock access to complete
Funding Insights of Takeda Pharmaceuticals
- Total Funding Total Funding
- Total Rounds 2
- Last Round Debt – Conventional — $30.9B
-
First Round
First Round
(30 Mar 2011)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2018 | Amount | Debt – Conventional - Takeda Pharmaceuticals | Valuation |
investors |
|
| Mar, 2011 | Amount | Grant - Takeda Pharmaceuticals | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Takeda Pharmaceuticals
Takeda Pharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Military Health. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Administers health care and support for military personnel and operations.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Takeda Pharmaceuticals
Takeda Pharmaceuticals has strategically engaged in corporate development activities, having acquired 19 companies. Notable acquisitions include Adaptate Biotherapeutics, Ariad Pharmaceuticals and IDM Pharma. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
T-cell-based immunotherapies for cancer treatment are developed.
|
2019 | ||||
|
Immunotherapeutics for cancer are developed using gamma delta T cells.
|
2016 | ||||
|
Novel enzyme therapeutics for celiac disease are engineered.
|
2015 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Takeda Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Takeda Pharmaceuticals Comparisons
Competitors of Takeda Pharmaceuticals
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Takeda Pharmaceuticals
Frequently Asked Questions about Takeda Pharmaceuticals
When was Takeda Pharmaceuticals founded?
Takeda Pharmaceuticals was founded in 1781 and raised its 1st funding round 230 years after it was founded.
Where is Takeda Pharmaceuticals located?
Takeda Pharmaceuticals is headquartered in Tokyo, Japan. It is registered at Tokyo, Tokyo, Japan.
How many employees does Takeda Pharmaceuticals have?
As of Mar 31, 2024, the latest employee count at Takeda Pharmaceuticals is 47,450.
What is the annual revenue of Takeda Pharmaceuticals?
Annual revenue of Takeda Pharmaceuticals is $29.18B as on Mar 31, 2024.
What does Takeda Pharmaceuticals do?
Takeda Pharmaceuticals is involved in the research, development, and manufacturing of innovative medicines. Focus areas include gastrointestinal and inflammatory diseases, rare diseases, plasma-derived therapies, oncology, neuroscience, and vaccines. Solutions are provided to address unmet medical needs worldwide, with operations spanning multiple countries. Sustainability and corporate responsibility are integrated into the business strategy to enhance climate-resilient health systems.
What products or services does Takeda Pharmaceuticals offer?
Takeda Pharmaceuticals offers Oveporexton (TAK-861), Plasma-Derived Therapies, and Oncology Treatments.
Is Takeda Pharmaceuticals publicly traded?
Yes, Takeda Pharmaceuticals is publicly traded on TSE under the ticker symbol 4502.
How many acquisitions has Takeda Pharmaceuticals made?
Takeda Pharmaceuticals has made 19 acquisitions, including Adaptate Biotherapeutics, Ariad Pharmaceuticals, and IDM Pharma.
Who are Takeda Pharmaceuticals's investors?
Takeda Pharmaceuticals has 1 investor. Key investors include Military Health.
What is Takeda Pharmaceuticals's ticker symbol?
The ticker symbol of Takeda Pharmaceuticals is 4502 on TSE.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.